Crescent Biopharma to Present at November Investor Conferences
Crescent Biopharma (Nasdaq: CBIO) announced management will present at three investor conferences in November 2025: a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Nov 11, 2025 at 8:00 a.m. ET in Boston; a fireside chat at the Stifel 2025 Healthcare Conference on Nov 12, 2025 at 1:20 p.m. ET in New York; and a fireside chat at the Jefferies Global Healthcare Conference on Nov 19, 2025 at 9:30 a.m. GMT (4:30 a.m. ET) in London.
Each presentation will be livestreamed from Crescent's investor website and a replay will be accessible for 90 days.
Crescent Biopharma (Nasdaq: CBIO) ha annunciato che la direzione parteciperà a tre conferenze per investitori nel novembre 2025: un colloquio informale alla Guggenheim 2nd Annual Healthcare Innovation Conference il 11 novembre 2025 alle 8:00 ET a Boston; un colloquio informale alla Stifel 2025 Healthcare Conference il 12 novembre 2025 alle 13:20 ET a New York; e un colloquio informale alla Jefferies Global Healthcare Conference il 19 novembre 2025 alle 9:30 GMT (4:30 ET) a Londra.
Ogni presentazione sarà trasmessa in diretta dal sito degli investitori di Crescent e la replica sarà accessibile per 90 giorni.
Crescent Biopharma (Nasdaq: CBIO) anunció que la dirección presentará en tres conferencias para inversionistas en noviembre de 2025: una conversación informal en la Guggenheim 2nd Annual Healthcare Innovation Conference el 11 de noviembre de 2025 a las 8:00 a.m. ET en Boston; una conversación informal en la Stifel 2025 Healthcare Conference el 12 de noviembre de 2025 a las 1:20 p.m. ET en Nueva York; y una conversación informal en la Jefferies Global Healthcare Conference el 19 de noviembre de 2025 a las 9:30 a.m. GMT (4:30 a.m. ET) en Londres.
Cada presentación se transmitirá en vivo desde el sitio web de inversores de Crescent y habrá una reproducción disponible durante 90 días.
Crescent Biopharma (Nasdaq: CBIO)는 경영진이 2025년 11월에 세 차례의 투자자 컨퍼런스에서 발표할 예정이라고 발표했습니다: 보스턴에서 열리는 Guggenheim 2nd Annual Healthcare Innovation Conference의 Nov 11, 2025 at 8:00 a.m. ET에 참석하는 Fireside Chat; 뉴욕에서 열리는 Stifel 2025 Healthcare Conference의 Nov 12, 2025 at 1:20 p.m. ET에 참가하는 Fireside Chat; 런던에서 열리는 Jefferies Global Healthcare Conference의 Nov 19, 2025 at 9:30 a.m. GMT (4:30 a.m. ET)에 열리는 Fireside Chat.
각 발표는 Crescent의 투자자 웹사이트에서 생중계되며 90일 동안 리플레이를 이용할 수 있습니다.
Crescent Biopharma (Nasdaq: CBIO) a annoncé que la direction présentera lors de trois conférences pour investisseurs en novembre 2025 : un entretien informel lors de la Guggenheim 2nd Annual Healthcare Innovation Conference le 11 novembre 2025 à 8:00 ET à Boston; un entretien informel lors de la Stifel 2025 Healthcare Conference le 12 novembre 2025 à 13:20 ET à New York; et un entretien informel lors de la Jefferies Global Healthcare Conference le 19 novembre 2025 à 9:30 GMT (4:30 ET) à Londres.
Chaque présentation sera diffusée en direct depuis le site investisseurs de Crescent et une rediffusion sera accessible pendant 90 jours.
Crescent Biopharma (Nasdaq: CBIO) gab bekannt, dass das Management bei drei Investorenkonferenzen im November 2025 auftreten wird: ein Fireside-Chat bei der Guggenheim 2nd Annual Healthcare Innovation Conference am 11. November 2025 um 8:00 Uhr ET in Boston; ein Fireside-Chat bei der Stifel 2025 Healthcare Conference am 12. November 2025 um 13:20 Uhr ET in New York; und ein Fireside-Chat bei der Jefferies Global Healthcare Conference am 19. November 2025 um 9:30 Uhr GMT (4:30 Uhr ET) in London.
Jede Präsentation wird live von Crescents Investoren-Website gestreamt und eine Wiedergabe wird für 90 Tage verfügbar sein.
Crescent Biopharma (Nasdaq: CBIO) أعلنت أن الإدارة ستشارك في ثلاث مؤتمرات للمستثمرين في نوفمبر 2025: جلسة حوار غير رسمية أثناء مؤتمر Guggenheim للابتكار في الرعاية الصحية لعامه الثاني في 11 نوفمبر 2025 الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة في بوسطن؛ وجلسة حوار غير رسمية أثناء مؤتمر Stifel للرعاية الصحية لعام 2025 في 12 نوفمبر 2025 الساعة 1:20 مساءً ET في نيويورك؛ وجلسة حوار غير رسمية أثناء مؤتمر Jefferies العالمي للرعاية الصحية في 19 نوفمبر 2025 الساعة 9:30 صباحاً GMT (4:30 صباحاً ET) في لندن.
سيتم بث كل عرض مباشرة من موقع Crescent للمستثمرين وسيكون بإمكان المشاهدة مرة أخرى لمدة 90 يوماً.
- None.
- None.
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:
- Guggenheim 2nd Annual Healthcare Innovation Conference, fireside chat on Tuesday, November 11, 2025, at 8:00 a.m. ET in Boston.
- Stifel 2025 Healthcare Conference, fireside chat on Wednesday, November 12, 2025, at 1:20 p.m. ET in New York.
- Jefferies Global Healthcare Conference, fireside chat on Wednesday, November 19, 2025, at 9:30 a.m. GMT (4:30 a.m. ET) in London.
A live webcast of each presentation will be available in the Investors section of Crescent's website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.
About Crescent Biopharma
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
Contact:
Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586